| Title |
Author |
Type |
Date |
Words |
| Starton Successfully Completes Proof of Concept Study for Transdermal Lenalidomide. |
|
|
Dec 27, 2019 |
853 |
| Medicinal Products Containing Everolimus Ii. |
|
|
Nov 22, 2019 |
127 |
| Janssen Receives EU Marketing Authorisation for Darzalex in Combination with Lenalidomide and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible. |
|
|
Nov 21, 2019 |
601 |
| Provision Of Medicinal Products Containing Everolimus Ii. |
|
|
Nov 20, 2019 |
135 |
| Conclusion Of A Non-exclusive Discount Contract Pursuant To 130a (8) Sgb V On Medicines Containing The Active Ingredient Everolimus (atc Code: L01xe10). |
|
|
Nov 19, 2019 |
462 |
| Framework Agreement For Drug Supply Paclitaxel (abraxane) - Lenalidomide (revlimid). |
|
|
Nov 19, 2019 |
116 |
| Lenalidomide Delays Progression in Smoldering Multiple Myeloma; Progression-free survival significantly longer with lenalidomide compared with observation. |
|
|
Nov 7, 2019 |
282 |
| Antineoplastics With The Active Substance Everolimus. |
|
|
Oct 31, 2019 |
102 |
| Open House Discounts 2019-19 - Everolimus. |
|
|
Oct 23, 2019 |
262 |
| Roche's Tecentriq In Combination With Avastin Improves Survival. |
|
|
Oct 21, 2019 |
199 |
| Genentech says Phase III IMbrave150 study met co-primary endpoints. |
|
|
Oct 21, 2019 |
226 |
| Completion Of Indication-limited Non-exclusive Discount Agreements Pursuant To 130a (8) Sgb V On Medicines Containing The Active Ingredient Everolimus (atc: L01xe10) - Patent-free Indications - Open-house Model. |
|
|
Oct 16, 2019 |
454 |
| Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a (8) Sgb V On Finished Medicinal Products Containing The Active Ingredient Everolimus, Atc L01xe10 - Here: Indication Breast Cancer. |
|
|
Sep 24, 2019 |
357 |
| Medicinal Products Containing Everolimus. |
|
|
Sep 18, 2019 |
124 |
| Conclusion Of A Non-exclusive Discount Agreement Pursuant To 130a (8) Sgb V On Finished Medicinal Products Containing The Active Ingredient Everolimus, Atc L01xe10, Patent-free Indication. |
|
|
Sep 18, 2019 |
386 |
| Supply Of Medicinal Products Containing Everolimus. |
|
|
Sep 17, 2019 |
193 |
| Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Substance Everolimus (only Indication Gi Net), Atc L01xe10, For The Period 1.11.2019 - 31.10.2021. |
|
|
Sep 17, 2019 |
240 |
| Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Substance Everolimus (exclusively Breast Cancer Indication), Atc L01xe10, For The Period 1.11.2019 - 31.10.2021. |
|
|
Sep 17, 2019 |
512 |
| Medicinal Products Containing The Active Substance Pazopanib. |
|
|
Aug 25, 2019 |
125 |
| China Recombinant Human Endostatin Investigation Market Report, 2019-2023. |
|
Report |
Aug 23, 2019 |
589 |
| Provision Of Medicinal Products Containing Pazopanib. |
|
|
Aug 22, 2019 |
189 |
| Supply Of Reagents, Fungible Material And Assignment Of Equipment To Perform The Determinations Of Everolimus, Mycophenolate, Topiramate, Buprenorphine And Ethylglucuronide In The Clinical Analysis Laboratory Of The University Hospital Are Spases. |
|
|
Aug 16, 2019 |
132 |
| Corrigendum to "Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features". |
|
Correction notice |
Aug 1, 2019 |
158 |
| Fragmin Inj 10x0,2ml/5000 Iu. |
|
|
Jul 25, 2019 |
110 |
| Fragmin Inj 1x10 Ml/10000 Iu. |
|
|
Jul 25, 2019 |
110 |
| Sunitinib Malate Market Research Report Overview, Scope, Top Manufacturers, and Forecast to 2025. |
|
Report |
Jul 23, 2019 |
892 |
| Supply Of Drugs For 2019: Pazopanib For Medical Use In Favor Of Citizens For The Purpose Of Their Social Security At The Expense Of The Budget Of The Astrakhan Region. |
|
|
Jul 20, 2019 |
133 |
| Supply Of Kits For Immunosuppressive Assays In The Blood (ciclosporin, Tacrolimus, Everolimus, Sirolimus) In Lc-ms/Ms Technique For The Pharmacotoxicology Laboratory Of The University Hospital Of Caen. |
|
|
Jul 13, 2019 |
170 |
| Do Not Ban Avastin, An Intraocular Injection -OSN. |
|
|
Jul 11, 2019 |
593 |
| Avastin Vial 100 Mg And Avastin Vial 400 Mg (spain-alcal De Henares: Antineoplastic Agents). |
|
|
Jul 11, 2019 |
117 |
| Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Ingredient Everolimus (atc Code: L01xe10) - Patent-free Indications - As Part Of A. |
|
|
Jul 5, 2019 |
146 |
| Johnson & Johnson (NYSE: JNJ) - Janssen Announces U.S. FDA Approval of DARZALEX[R] (daratumumab) in Combination with Lenalidomide and Dexamethasone for Newly Diagnosed Patients with Multiple Myeloma Who Are Transplant Ineligible -- 27/6/2019. |
|
|
Jul 4, 2019 |
492 |
| Delivery Of Medicinal Products By Atc Group L04ax04 - Lenalidomide For Hospitals Cesk Budejovice, As. |
|
|
Jul 1, 2019 |
113 |
| Preparation and Evaluation of Inflammation Targeted Nano-micellar Formulation of Celecoxib. |
Bahadori, Fatemeh; Buyuk, Ayse Smyrna; Kozanoglu, Ahmed Serdar; Eskandari, Zahra; Ankarali, Handan; |
|
Jul 1, 2019 |
4256 |
| United States : Janssen Announces U.S. FDA Approval of DARZALEX (daratumumab) in Combination with Lenalidomide and Dexamethasone for Newly Diagnosed Patients with Multiple Myeloma Who Are Transplant Ineligible. |
|
|
Jun 29, 2019 |
562 |
| Drug Delivery - Avastin - L01xc07 (czechia-prague: Antineoplastic Agents). |
|
|
Jun 14, 2019 |
124 |
| Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Ingredient Everolimus (atc Code: L01xe10) - Patent-free Indications - As Part Of A. |
|
|
May 31, 2019 |
150 |
| Celgene Corporation (NASDAQ: CELG) - FDA Approves REV LI MID[R] (Lenalidomide) In Combination With Rituximab For the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma -- 28/5/2019. |
|
|
May 29, 2019 |
622 |
| US Food and Drug Administration grants approval to Pfizer's Fragmin injection. |
|
|
May 20, 2019 |
189 |
| US Food and Drug Administration grants approval to Pfizer's Fragmin injection. |
|
|
May 20, 2019 |
185 |
| United States : FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots. |
|
|
May 17, 2019 |
805 |
| Procurement Of Everolimus Eluting Balloon Mounted Platinumn Chromium Stent System. |
|
|
Apr 13, 2019 |
150 |
| Supply of Everolimus 0.75 Mg Tab. |
|
|
Apr 9, 2019 |
150 |
| Drug Delivery - Avastin - L01xc07. |
|
|
Apr 3, 2019 |
157 |
| 8201n001-tab. Everolimus 0.25 Mg. In Strip Packing. Firm~s Offer: Brand As Accepted: Evergraf 0.25. (hsn Code-3004-9099) Mfgd. & Mktd. By M/s. Panacea Biotech Ltd. |
|
|
Apr 1, 2019 |
102 |
| 8201n001-cap. Lenalidomide 5 Mg Brand- Lenangio 5 Mfg In India By :- Naprod Life Science Pvt. Ltd, G-17/1, M.i.d.c., Tarapur, Boisar, Dist.-thane-401506 Marketed By:- Dr. Reddy~s Laboratories Ltd., Gl. |
|
|
Mar 28, 2019 |
103 |
| Procurement Of Everolimus Eluting Balloon Mounted Platinum Chromium Coronary Stent System. |
|
|
Mar 23, 2019 |
149 |
| Cancer patient is denied 'vital' drug because she lives wrong side of border. |
|
|
Mar 19, 2019 |
633 |
| Cancer patient denied 'vital' drug because she lives half a mile wrong side of border. |
|
|
Mar 18, 2019 |
627 |
| Terminally ill cancer patient denied life-prolonging drug because she lives HALF A MILE over the border; Joannah Houghton, who gets chemotherapy treatment at Clatterbridge Cancer Centre in Wirral, misses out on Avastin by a journey of just three minutes. |
|
|
Mar 17, 2019 |
749 |
| Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On Finished Medicinal Products With The Active Ingredient Everolimus, Atc L01xe10, Patent-free Indication. |
|
|
Feb 27, 2019 |
378 |
| Pfizer Receives European Approval for Zirabev, a Biosimilar to Avastin. |
|
|
Feb 21, 2019 |
250 |
| Pfizer reports European approval for biosimilar to Avastin. |
|
|
Feb 19, 2019 |
118 |
| Roche says CHMP recommends EU approval of Tecentriq in combination with Avastin. |
|
|
Feb 1, 2019 |
144 |
| Conclusion Of A Non-exclusive Discount Contract According To 130a Abs. 8 Sgb V On Medicines Containing The Active Ingredient Dalteparin (atc-code: B01ab04). |
|
|
Feb 1, 2019 |
501 |
| Open House Discounts 2019-04 - Everolimus. |
|
|
Jan 31, 2019 |
254 |
| Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs.8 Sgb V On The Active Substance Everolimus (patent-free Indications), Atc Code: L04aa18 & L01xe10, For The Period From 1.3.2019 To 28.2.2021. |
|
|
Jan 29, 2019 |
262 |
| FDA Approves Genentech's Tecentriq in Combination with Avastin and Chemotherapy for the Initial Treatment of People with a Specific Type of Metastatic Lung Cancer. |
|
|
Dec 11, 2018 |
624 |
| Switzerland : FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer. |
|
|
Dec 10, 2018 |
282 |
| United States : FDA Approves Genentechs Tecentriq in Combination With Avastin and Chemotherapy for the Initial Treatment of People With a Specific Type of Metastatic Lung Cancer. |
|
|
Dec 10, 2018 |
290 |
| 82028825-(ph No. : 25098) Bevacizumab 100 Mg Inj. Accepted Description Same As Tendered Description. Brand: Cizumab 100. Mfd By M/s.hetero Biopharma Ltd. Mktd By M/s. Hetero Healthcare Ltd. |
|
|
Dec 10, 2018 |
101 |
| Premature Bebeklerde Retinopati Gelisimine Etki Eden Risk Faktorlerinin Degerlendirilmesi/Evaluation of Risk Factors Affecting Development of Retinopathy in Premature Infants. |
Gul, Filiz; Bulbul, Ali |
Report |
Dec 1, 2018 |
4483 |
| Bevacizumab 2017 (czech Republic-brno: Antineoplastic Agents). |
|
|
Nov 4, 2018 |
112 |
| WET AMD DRUG RULING. |
|
Brief article |
Nov 1, 2018 |
149 |
| Tender For The Supply Of Ilaris, Cosentyx And Votubia, With Negotiated Procedure Without Publication Of A Tender Notice - Dpdddp.p 114/2018. (cyprus-nicosia: Antineoplastic And Immunomodulating Agen. |
|
|
Oct 30, 2018 |
204 |
| Everolimus (czech Republic-brno: Antineoplastic Agents). |
|
|
Oct 30, 2018 |
120 |
| Supply Of Exclusive Medicines: Canakinumab, Everolimus, Lapatinib, Nilotinib, Pazopanib, Ruxolitinib, In Its Different Presentations, For All The Centers Affiliated To The Pls De Sevilla. |
|
|
Oct 28, 2018 |
106 |
| Supply Of Exclusive Medicines: Canakinumab, Everolimus, Lapatinib, Nilotinib, Pazopanib, Ruxolitinib, In Its Different Presentations, For All The Centers Attached To The Pls Of Seville. |
|
|
Oct 28, 2018 |
104 |
| Application of Lenalidomide on Diffused Large B-cell Lymphoma: Salvage, Maintenance, and Induction Treatment. |
Ma, Li-Yangxue; Su, Li |
Report |
Oct 20, 2018 |
2492 |
| Supply Of Exclusive Medicines: Dabrafenib, Everolimus, Nilotinib, Ranibizumab, Ruxolitinb. |
|
|
Oct 19, 2018 |
117 |
| Exclusive Medicines Supply: Bevacizumab 400 Mg, Bevacizumab 100 Mg, Pertuzumab 420 Mg. |
|
|
Oct 16, 2018 |
118 |
| A PS1.3 million victory for common sense. |
|
|
Oct 4, 2018 |
703 |
| Supply Of Medicinal Products With The Active Substance Bevacizumab. |
|
|
Sep 29, 2018 |
183 |
| Health leaders cheer High Court victory for cheaper eye treatment; Case was brought by pharmaceutical giants Bayer and Novartis against 12 CCGs - including Stockton and Hartlepool. |
|
|
Sep 28, 2018 |
708 |
| Conclusion Of A Non-exclusive Discount Agreement According To 130a Abs. 8 Sgb V On The Active Substance Dalteparin, Atc B01ab04, For The Period 1.11.2018 - 31.10.2020. |
|
|
Sep 23, 2018 |
513 |
| NHS legal win in big pharma drugs battle. |
|
|
Sep 22, 2018 |
118 |
| Leiters to ship new repackaged Avastin under US FDA 2018 guidance. |
|
|
Sep 20, 2018 |
214 |
| Leiters to ship new repackaged Avastin under US FDA 2018 guidance. |
|
|
Sep 20, 2018 |
210 |
| Rituximab + Lenalidomide Effective in Follicular Lymphoma; Response rate, progression-free survival comparable to those seen with rituximab-chemotherapy. |
|
|
Sep 11, 2018 |
248 |
| Cytostatics And Immunomodulators - Bevacizumab. |
|
|
Sep 1, 2018 |
133 |
| Effects of Two-by-Two Combination Therapy with Valproic Acid, Lithium Chloride, and Celecoxib on the Angiogenesis of the Chicken Chorioallantoic Membrane. |
Afzal, Ehsan; Alinezhad, Sedigheh; Khorsand, Marjan; Khoshnood, Mohammad Javad; Takhshid, Mohammad A |
|
Sep 1, 2018 |
4220 |
| JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer. |
|
|
Aug 31, 2018 |
476 |
| Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Everolimus (atc: L01xe10) As Part Of A So-called Open-house Model. |
|
|
Aug 3, 2018 |
493 |
| Supply Of Lenalidomide. |
|
|
Jul 27, 2018 |
101 |
| Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Dalteparin (atc: B01ab04) Within The Framework Of A So-called Open-house Model. (germany-eisenberg: Pharmaceutical Products). |
|
|
Jul 26, 2018 |
136 |
| United States : FDA grants Breakthrough Therapy Designation for Roches Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC). |
|
|
Jul 18, 2018 |
437 |
| United States : FDA Grants Breakthrough Therapy Designation for Genentechs TECENTRIQ in Combination With Avastin as First-Line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC). |
|
|
Jul 18, 2018 |
492 |
| Genistein Improves Liver Damage in Male Mice Exposed to Morphine. |
Salahshoor, Mohammad; Roshankhah, Shiva; Hosseni, Payman; Jalili, Cyrus |
Report |
Jul 5, 2018 |
5149 |
| CORRELATION OF INTRAOCULAR PRESSURE WITH OCULAR AXIAL LENGTH AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB IN DIABETIC MACULAR EDEMA. |
|
Report |
Jun 30, 2018 |
3237 |
| Supply Of Exclusive Medicines Bevacizumab 400 Mg, Bevacizumab 100 Mg, Pertuzumab 420 Mg, Rituximab 1 400 Mg. |
|
|
Jun 28, 2018 |
114 |
| Fn Motol - Bevacizumab 100 Mg (czech Republic-prague: Antineoplastic Agents). |
|
|
Jun 25, 2018 |
116 |
| Roche receives USFDA approval for Avastin. |
|
|
Jun 15, 2018 |
136 |
| Roche receives USFDA approval for Avastin. |
|
|
Jun 15, 2018 |
132 |
| Genentech says FDA approves Avastin plus chemotherapy in ovarian cancer. |
|
|
Jun 13, 2018 |
262 |
| FDA approves Genentech's Avastin plus chemo for ovarian cancer treatment. |
|
|
Jun 13, 2018 |
152 |
| Eveolimus; No. -08131-18 Delivery Of Everolimus Medicinal Product. |
|
|
Jun 10, 2018 |
136 |
| Supply Of Medicine Tab Lenalidomide 25mg. |
|
|
Jun 6, 2018 |
151 |
| Adjunctive Everolimus Therapy for Treatment-resistant Focal-onset Seizures Associated with Tuberous Sclerosis: A Phase 3, Randomised, Double-blind, Placebo-controlled Study/Tuberoskleroz ile Iliskili, Tedaviye Direncli Fokal Baslangicli Nobetler icin Yardimci Everolimus Tedavisi: 3 Asamali, Randomize, Cift Kor, Plasebo Kontrollu Calisma. |
Karaoglan, Mustafa |
Report |
Jun 1, 2018 |
784 |
| Request No. 7271/208, Everolimus, Compressed 0.25 Mg, Code Igss 10513. |
|
|
May 25, 2018 |
102 |
| Request No. 7272/208, Everolimus, Compressed 0.25 Mg, Code Igss 10513. |
|
|
May 25, 2018 |
102 |
| Switzerland : Phase III IMpower150 study showed Roches Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel. |
|
|
May 18, 2018 |
480 |
| Bevacizumab; Delivery Of Medicinal Products (bevacizumab) To Provide Citizens Of The Russian Federation Who Are On The Territory Of The Republic Of Tatarstan And Who Have The Right To Receive State Social Assistance In Accordance With The Federal Law Of J. |
|
|
May 13, 2018 |
117 |
| Short term clinical outcomes of Everolimus-eluting stents in patients with stable angina pectoris. |
|
Report |
Apr 30, 2018 |
3094 |
| Role of intravitreal bevacizumab in management of Eale's Disease. |
|
|
Apr 30, 2018 |
3499 |
| Procurement Of Everolimus Eluting Balloon Mounted Coronary Stent System. |
|
|
Apr 25, 2018 |
188 |
| FDA to hold a joint committee meeting. |
|
|
Apr 24, 2018 |
101 |
| Supply of Medicine Tab Pazopanib 400mg. |
|
|
Apr 23, 2018 |
162 |
| Celecoxib Lowers Opioid Use Post Head & Neck Cancer Surgery; Decreased opioid use seen after head and neck cancer surgery with free tissue reconstruction. |
|
|
Apr 23, 2018 |
242 |
| Supply Of The Exclusive Medicine Lenalidomide Capsules. |
|
|
Apr 15, 2018 |
105 |
| Neonatal Genistein Exposure and Glucocorticoid Signaling in the Adult Mouse Uterus. |
Whirledge, Shannon D.; Kisanga, Edwina P.; Oakley, Robert H.; Cidlowski, John A. |
Report |
Apr 1, 2018 |
12057 |
| Roche's phase III lung cancer study of Tecentriq combined with Avastin indicates clinically significant survival benefit. |
|
|
Mar 27, 2018 |
258 |
| Roche's phase III lung cancer study of Tecentriq combined with Avastin indicates clinically significant survival benefit. |
|
|
Mar 27, 2018 |
254 |
| Genentech Study Shows Addition of Tecentriq to Avastin /Carboplatin / Paclitaxel Extends Lifetime of People with Advanced Lung Cancer. |
|
|
Mar 27, 2018 |
399 |
| Genentech says Phase III IMpower150 study met co-primary endpoint. |
|
|
Mar 26, 2018 |
122 |
| Roche issues challenge to Bristol, Merck cancer drugs with Tecentriq cocktail. |
|
|
Mar 26, 2018 |
349 |
| Dalteparin Sodium (dosage Form: Pre-filled Syringes). |
|
|
Mar 21, 2018 |
382 |
| Supply Of Medicinal Products With The Active Substance Pazopanib. |
|
|
Mar 20, 2018 |
152 |
| Supply Of Medicinal Products With The Active Substance Everolimus. |
|
|
Mar 17, 2018 |
174 |
| Pars plana vitrectomy in vitreous hemorrhage with or without Intravitreal Bevacizumab: A comparative overview. |
|
Report |
Feb 28, 2018 |
3443 |
| Exclusive Medication Supply Lenalidomide Capsules. |
|
|
Feb 16, 2018 |
104 |
| Roche's Tecentriq and Avastin combination decreases risk of disease worsening or death in Phase III cancer study. |
|
|
Feb 8, 2018 |
193 |
| Roche's Tecentriq and Avastin combination decreases risk of disease worsening or death in Phase III cancer study. |
|
|
Feb 8, 2018 |
189 |
| Roche IMmotion 151 phase 3 study saw TECENTRIQ and Avastin reduced KD risk. |
|
|
Feb 5, 2018 |
255 |
| WET AMD DRUG DISPUTE. |
|
|
Feb 1, 2018 |
454 |
| United States : Bevacizumab dramatically improves severe hereditary hemorrhagic telangiectasia (HHT) associated bleeding. |
|
|
Jan 30, 2018 |
739 |
| Amgen and Allergan's MVASI (Biosimilar Bevacizumab) Approved by European Commission for Treatment of Certain Cancers. |
|
|
Jan 24, 2018 |
362 |
| Supply Of Fn Motol - Bevacizumab 100 Mg. |
|
|
Jan 23, 2018 |
120 |
| Bevacizumab 2015. |
|
|
Jan 22, 2018 |
119 |
| Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. |
|
|
Jan 19, 2018 |
300 |
| Amgen & Allergan's MVASI (Biosimilar Bevacizumab) approved by EC for certain types of cancer. |
|
|
Jan 19, 2018 |
296 |
| Procurement Of Tacrolimus 2 Mg Tab, Tadalafil 10mg Tab, Tamoxifen Citrate 20 Mg Tab. |
|
|
Jan 18, 2018 |
144 |
| CCGs facing legal dispute over use of cancer drug as wet AMD treatment option. |
|
|
Jan 9, 2018 |
636 |
| CCGs facing legal dispute over use of cancer drug as wet AMD treatment option. |
|
|
Jan 9, 2018 |
640 |
| Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer. |
Yang, R.F.; Yu, B.; Zhang, R.Q.; Wang, X.H.; Li, C.; Wang, P.; Zhang, Y.; Han, B.; Gao, X.X.; Zhang, |
Report |
Jan 1, 2018 |
5456 |
| Thrombotic Thrombocytopenic Purpura Associated with Pazopanib. |
Syed, Umer; Wahlberg, Kramer J.; Douce, Daniel R.; Sprague, Julian R. |
|
Jan 1, 2018 |
1493 |
| Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features. |
Khan, Abdullah M.; Muzaffar, Jameel; Murthy, Hermant; Wingard, John R.; Moreb, Jan S. |
|
Jan 1, 2018 |
4143 |
| Preemptive Analgesia in Total Knee Arthroplasty: Comparing the Effects of Single Dose Combining Celecoxib with Pregabalin and Repetition Dose Combining Celecoxib with Pregabalin: Double-Blind Controlled Clinical Trial. |
Lubis, Andri M.T.; Rawung, Rangga B.V.; Tantri, Aida R. |
|
Jan 1, 2018 |
4215 |
| Modulation of Adipocyte Differentiation and Proadipogenic Gene Expression by Sulforaphane, Genistein, and Docosahexaenoic Acid as a First Step to Counteract Obesity. |
Valli, Veronica; Heilmann, Katharina; Danesi, Francesca; Bordoni, Alessandra; Gerhauser, Clarissa |
|
Jan 1, 2018 |
4491 |
| Synthesis, Characterization, and Biodistribution of Quantum Dot-Celecoxib Conjugate in Mouse Paw Edema Model. |
Kalangi, Suresh K.; Swarnakar, Nitin K.; Sathyavathi, R.; Rao, D. Narayana; Jain, Sanyog; Reddanna, |
|
Jan 1, 2018 |
4952 |
| Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac. |
Walker, Chris |
|
Jan 1, 2018 |
8781 |
| Synthesis, Characterization, and Antioxidant Activities of Genistein, Biochanin A, and Their Analogues. |
Sherif, Salah Hamza; Gebreyohannes, BerihuTekluu |
|
Jan 1, 2018 |
4782 |
| A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide. |
Siricilla, Mamatha; Irwin, Lydia; Ferber, Andres |
|
Jan 1, 2018 |
4962 |
| Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient. |
Patel, Serena; Mendler, Michel H.; Valasek, Mark A.; Tsunoda, Shirley M. |
|
Jan 1, 2018 |
3619 |
| An Interesting Case and Literature Review of a Coronary Stent Fracture in a Current Generation Platinum Chromium Everolimus-Eluting Stent. |
Aung, Sammy San Myint; Latt, Htun; Kyaw, Kyaw; Roongsritong, Chanwit |
|
Jan 1, 2018 |
2326 |
| Refractive and Biometrie Outcomes in Patients with Retinopathy of Prematurity Treated with Intravitreal Injection of Ranibizumab as Compared with Bevacizumab: A Clinical Study of Correction at Three Years of Age. |
Chen, Yen-Chih; Chen, San-Ni; Yang, Benjamin Chi-Lan; Lee, Kun-Hsien; Chuang, Chih-Chun; Cheng, Chie |
Correction notice |
Jan 1, 2018 |
4240 |
| Combined Application of Bevacizumab and Mitomycin C or Bevacizumab and 5-Fluorouracil in Experimental Glaucoma Filtration Surgery. |
Zuo, Lei; Zhang, Jianhong; Xu, Xun |
|
Jan 1, 2018 |
7550 |
| Genistein Exposure Interferes with Pharmacokinetics of Celecoxib in SD Male Rats by UPLC-MS/MS. |
Zheng, Xiang; Wen, Jian; Liu, Teng-hui; Ou-yang, Qiu-Geng; Cai, Jian-ping; Zhou, Hong-yu |
|
Jan 1, 2018 |
3949 |
| Lenalidomide 10mg Cap. |
|
|
Dec 20, 2017 |
136 |
| China : JHL Submits Clinical Trial Application for Proposed Bevacizumab Biosimilar. |
|
|
Dec 18, 2017 |
142 |
| Medicinal Products Containing Everolimus. |
|
|
Dec 18, 2017 |
105 |
| Framework Agreement With A Single Winner By Negotiation Without Advertising For Exclusivity Of The Supply Of The Drug Lenalidomide (revlimid) (spain-oviedo: Various Medicinal Products). |
|
|
Dec 15, 2017 |
120 |
| Roche's combination of Tecentriq and Avastin plus chemotherapy extends lung cancer patients' lives in Phase III study. |
|
|
Dec 11, 2017 |
178 |
| Roche's combination of Tecentriq and Avastin plus chemotherapy extends lung cancer patients' lives in Phase III study. |
|
|
Dec 11, 2017 |
182 |
| FDA Grants Genentech's Avastin Full Approval for Most Aggressive form of Brain Cancer. |
|
|
Dec 8, 2017 |
338 |
| Tecentriq and Avastin Plus Chemotherapy Doubles PFS Compared to Avastin Plus Chemo in Advanced NSCLC. |
|
|
Dec 8, 2017 |
415 |
| FDA grants full approval for Genentech's Avastin. |
|
|
Dec 5, 2017 |
155 |
| Genentech Study of Tecentriq (atezolizumab) and Avastin (bevacizumab) Plus Chemotherapy Meets Primary Endpoint of PFS in Advanced Non-squamous NSCLC. |
|
|
Nov 27, 2017 |
456 |
| Medicinal Products Containing Bevacizumab, Trastuzumab, Trastuzumab, Emtansin And Pertuzumab. |
|
|
Nov 24, 2017 |
134 |
| Switzerland : Phase III IMpower150 study showed Roches TECENTRIQ (atezolizumab) and Avastin (bevacizumab) plus chemotherapy significantly reduced the risk of disease worsening or death in the initial treatment of people with a type of advanced lung cancer. |
|
|
Nov 21, 2017 |
243 |
| Pnsp 21/2017 Dabrafenib, Nilotinib, Everolimus, Lapatinib, Pazopanib, Basiliximab, Mycophenolic Acid, Verteporfin And Octreotide. (spain-madrid: Pharmaceutical Products). |
|
|
Nov 21, 2017 |
115 |
| FDA Grants Pfizer Approval of Sutent (sunitinib malate) as Adjuvant Treatment in Adults with High Risk of Recurrent RCC Following Nephrectomy. |
|
|
Nov 20, 2017 |
309 |
| United States : Phase III IMpower150 Study Showed Genentechs Tecentriq (Atezolizumab) and Avastin (Bevacizumab) Plus Chemotherapy Significantly Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Lung. |
|
|
Nov 20, 2017 |
249 |
| Supply Of 1.01 valganciclovir 450 Mg Tab1.02 lenalidomide 25 Mg Cap1.03 hydrocortisone Enema 10x W/w1.04 tab Everolimus 10 Mg. |
|
|
Nov 19, 2017 |
130 |
| Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. |
|
|
Nov 16, 2017 |
260 |
| Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. |
|
|
Nov 16, 2017 |
256 |
| Supply Of Tab Pazopanib 400 Mg. |
|
|
Nov 9, 2017 |
103 |
| Opdivo (nivolumab) Shows Three-Year Survival Benefit in Advanced RCC, Reducing Risk of Death by 26% versus Everolimus in CheckMate -025 study. |
|
|
Nov 7, 2017 |
409 |
| United States : 1818 Duration of Therapy (DOT) and Time to Next Therapy (TTNT) of Bortezomib, Carfilzomib and Ixazomib Combinations with Lenalidomide/Dexamethasone (VRd, KRd, IRd) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Clinica. |
|
Clinical report |
Nov 5, 2017 |
324 |
| 'We cannot allow NHS to be held to ransom'. |
|
|
Nov 1, 2017 |
585 |
| Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. |
Bukhari, Nedal |
Report |
Nov 1, 2017 |
1532 |
| US FDA receives Roche's supplemental biologics license application for Avastin. |
|
|
Oct 30, 2017 |
173 |
| US FDA receives Roche's supplemental biologics license application for Avastin. |
|
|
Oct 30, 2017 |
169 |
| Supply Of Dalteparin (fragmin) In A Range Of Presentations To Health Boards Across Nhs Scotland. |
|
|
Oct 30, 2017 |
113 |
| FDA reviews Roche's Avastin as first-line treatment for ovarian cancer. |
|
|
Oct 27, 2017 |
227 |
| FDA reviews Roche's Avastin as first-line treatment for ovarian cancer. |
|
|
Oct 27, 2017 |
223 |
| FDA Grants Denovo Biopharma Permission to Proceed with Clinical Trial of DB102 (Enzastaurin) in Diffuse Large B Cell Lymphoma. |
|
|
Oct 25, 2017 |
259 |
| Supply Of Medicines For Use Of Individual Patients :nj Trastuzumab 150 Mg Nos 4 ,tab Lenalidomide 25 Mg Nos 30,inj Carfilzomib 60 Mg Nos 3,inj Fosaprepitant Dimeglumine 150 Mg. |
|
|
Oct 22, 2017 |
156 |
| Drug Delivery - Afinitor (l01xe10), Aubagio 14 Mg (l04aa31), Avastin (l01xc07), Opdivo (l01xc17), Orencia (l04aa24). (czech Republic-prague: Antineoplastic Agentsnd). |
|
|
Oct 3, 2017 |
126 |
| Supply Of Medical Stores To Command Hospital (cc) Lucknow : Drug Eluting Everolimus Cobalt Chromium/platinum Chromium Plateform Stent Assorted Sizes,drug Eluting Coronary Balloon With Urea Pacltaxel Coating Assorted Sizes,cto Balloon Dilatation catheter. |
|
|
Sep 30, 2017 |
144 |
| Supply Of Tab Everolimus 5 Mg. |
|
|
Sep 26, 2017 |
103 |
| Tab.votrient 400mg Pazopanib. |
|
|
Sep 19, 2017 |
334 |
| Inj. Fragmin 7500 Iu. |
|
|
Sep 18, 2017 |
101 |
| United States : FDA approves first biosimilar for the treatment of cancer. |
|
|
Sep 16, 2017 |
783 |
| Medicinal Products Containing Pazopanib. |
|
|
Sep 16, 2017 |
122 |
| Medicinal Products Containing Everolimus. |
|
|
Sep 16, 2017 |
125 |
| Women denied cancer drug. |
|
|
Sep 15, 2017 |
317 |
| Drug denied to cervical cancer patients INWALES. |
|
|
Sep 15, 2017 |
536 |
| Tablet Pazopanib 400 Mg. |
|
|
Sep 15, 2017 |
252 |
| Injection Containing Bevacizumab 100 Mg. |
|
|
Sep 15, 2017 |
253 |
| Tab Pazopanib 400mg. |
|
|
Sep 11, 2017 |
120 |
| Tab.votrient 400mg Pazopanib. |
|
|
Sep 11, 2017 |
334 |
| P.h.no.25075) Cap Sutent (sunitinib Malate 50 Mg). |
|
|
Aug 30, 2017 |
112 |
| Medicinal Products Containing Bevacizumab. |
|
|
Aug 23, 2017 |
123 |
| Delivery Of Medicines (inn: Pazopanib) In 2017 To Provide Medicines And Medical Products To Certain Groups Of The Population In The Municipality Of The Resort City Of Gelendzhik In 2017. |
|
|
Aug 14, 2017 |
101 |
| Tab.votrient 400mg Pazopanib. |
|
|
Aug 12, 2017 |
334 |
| Tab. Everolimus 5mg In Strip Packing. |
|
|
Aug 3, 2017 |
116 |
| (ph No.:23016) Everolimus 0.5 Mg Tab. |
|
|
Aug 1, 2017 |
109 |
| United States : Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin1 (bevacizumab). |
|
|
Jul 26, 2017 |
223 |
| B325 - Bevacizumab (25 Mg/Ml; 100 Mg/4 Ml; Conc. For The Infusion; Frs; B326 - Bevacizumab (25 Mg/Ml; 400 Mg/16 Ml; Conc. T1238 - Trastuzumab (600 Mg/5 Ml; Sols Inj., Sc; Frs). |
|
|
Jul 22, 2017 |
101 |
| Health services warn over counterfeit cancer drug sold in the north. |
|
|
Jul 14, 2017 |
262 |
| Supply Of Medicine Linagliptin 5 Mg Tab, Nandrolone Decanoate 50 Mg/ml, 1 Ml Vial Inj, Pazopanib 400 Mg Tab, Pregabalin 75 Mg + Methylcoblamine 750 Mcg tab, Sitagliptin 50mg Tab, Insulin Aspart 30%, Insulin Aspart Protamine 70% (100 Iu/ml, 3ml Vial) Inj. |
|
|
Jul 8, 2017 |
158 |
| Botulinum Toxin Type A; Deferasirox; Emtricitabine, Tenofovir Disoproxil And Efavirenz; Entecavir; Everolimus; Peginterferon Beta-1a; Rotigotine; Sunitinib; Teriflunomide. |
|
|
Jul 7, 2017 |
124 |
| Delivery Of Medicines - Afinitor (l01xe10) Aubagio 14mg (l04aa31), Avastin (l01xc07) opdivo (l01xc17), Orencia (l04aa24). |
|
|
Jul 4, 2017 |
131 |
| United States : Amgen And Allergan Announce FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab. |
|
|
Jun 10, 2017 |
274 |
| Angiogenesis and Tumor Progression Inhibition of Cyclooxygenase-2 Selective Inhibitor Celecoxib Associated with Poly (lactic-co-glycolic acid) in Tumor Cell Line Resistant to Chemotherapy/Inhibicion de Angiogenesis y Progresion Tumoral por Inhibidor Selectivo de Ciclooxigenasa-2 Celecoxib Asociado con Acido (poli lactico co-glicolico) en Linea de Celulas Tumorales Resistentes a Quimioterapia. |
Roa, Ignacio; Cantin, Mario; Vilos, Cristian; Rosas, Carlos; Lemus, David |
|
Jun 1, 2017 |
4380 |
| Provision Of Avastin. |
|
|
May 19, 2017 |
118 |
| Fn Motol Bevacizumab. |
|
|
May 11, 2017 |
111 |
| United States : Avastin as effective as Eylea for treating central retinal vein occlusion. |
|
|
May 10, 2017 |
795 |
| Inhibitors Of Protein Kinases - Everolimus. |
|
|
Apr 29, 2017 |
202 |
| Dalteparin replacement of unfractionated heparin (UFH) for extracorporeal circuit (ECC) anticoagulation in an outpatient hemodialysis unit. |
Campbell, Lesley; Schneider, Maryann |
Brief article |
Apr 1, 2017 |
267 |
| Medicines Containing Bevacizumab, Trastuzumab, Trastuzumab Emtansin And Pertuzumab. |
|
|
Mar 22, 2017 |
228 |
| Celecoxib scores ok on cardiac safety: a three-drug, 10-year trial found it equivalent, or "noninferior," to ibuprofen and naproxen. |
|
|
Mar 1, 2017 |
589 |
| IMPROVEMENT OF GROWTH PERFORMANCE AND INTESTINAL DIGESTIVE FUNCTION IN BROILER CHICKENS BY SUPPLEMENTATION OF SOY ISOFLAVONE IN CORN-SOY DIET. |
|
Report |
Feb 28, 2017 |
4228 |
| Genentech Touts Study Data for Tecentriq, Avastin Combo in Locally Advanced or Metastatic Renal Cell Carcinoma. |
|
|
Feb 22, 2017 |
682 |
| Tracon Pharmaceuticals' combination of TRC105 with Avastin fails to perform better than Avastin. |
|
|
Feb 14, 2017 |
199 |
| Tracon Pharmaceuticals' combination of TRC105 with Avastin fails to perform better than Avastin. |
|
|
Feb 14, 2017 |
195 |
| A clinical study on management of corneal neovascularisation to prevent Corneal transplant failure. |
Raman, Niraimozhi; Gnanaselvan, Helen Rosita |
Report |
Feb 13, 2017 |
2731 |
| Celgene Receives Positive CHMP Opinion to Expand Revlimid (Lenalidomide) Indication. |
|
|
Jan 27, 2017 |
571 |
| Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System. |
Bai, Yongrui; Xu, Yuejuan; Wu, Bin |
Report |
Jan 1, 2017 |
4331 |
| Dietary Genistein Influences Number of Acetylcholine Receptors in Female Diabetic Jejunum. |
Schacht, Sydney; Masood, Faisal; Catmull, Shawn; Dolan, Robert; Altabtabaee, RussL; Grow, Wade; Nakk |
Report |
Jan 1, 2017 |
4960 |
| Everolimus Implicated in Case of Severe Gastrointestinal Hemorrhage. |
Gonzales, Paul; Klusewitz, Seth; Marowske, Johanna; Gancayco, John; Osswald, Michael B.; Setlik, Rob |
Clinical report |
Jan 1, 2017 |
2028 |
| Design and Characterization of Endostatin-Loaded Nanoparticles for In Vitro Antiangiogenesis in Squamous Cell Carcinoma. |
Adeyemi, Samson A.; Choonara, Yahya E.; Kumar, Pradeep; du Toit, Lisa C.; Pillay, Viness |
|
Jan 1, 2017 |
9552 |
| Modeling of Tumor Growth Incorporating the Effects of Necrosis and the Effect of Bevacizumab. |
Drexler, Daniel Andras; Sapi, Johanna; Kovacs, Levente |
Report |
Jan 1, 2017 |
7532 |
| Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes. |
Xu, Song; Li, Li; Li, Min; Zhang, Mengli; Ju, Mei; Chen, Xu; Gu, Heng |
Report |
Jan 1, 2017 |
11223 |
| Protective Effects of Genistein against Mono-(2-ethylhexyl) Phthalate-Induced Oxidative Damage in Prepubertal Sertoli Cells. |
Zhang, Liandong; Gao, Ming; Zhang, Tongdian; Chong, Tie; Wang, Ziming; Zhai, Xiaoqiang; Wu, Zhizhong |
Report |
Jan 1, 2017 |
6668 |
| Antiangiogenic Therapy for Diabetic Nephropathy. |
Tanabe, Katsuyuki; Maeshima, Yohei; Sato, Yasufumi; Wada, Jun |
Report |
Jan 1, 2017 |
9397 |
| The Phytoestrogen Genistein Produces Similar Effects as 17[beta]-Estradiol on Anxiety-Like Behavior in Rats at 12 Weeks after Ovariectomy. |
Rodriguez-Landa, Juan Francisco; Cueto-Escobedo, Jonathan; Puga-Olguin, Abraham; Rivadeneyra-Domingu |
Report |
Jan 1, 2017 |
7646 |
| Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy. |
Tan, Jeffrey J.; Cai, Charles L.; Shrier, Eric M.; McNally, Lois; Lazzaro, Douglas R.; Aranda, Jacob |
|
Jan 1, 2017 |
8750 |
| Bevacizumab (Avastin) and Thermal Laser Combination Therapy for Peripapillary Choroidal Neovascular Membranes. |
Adrean, Sean D.; Grant, Scott; Chaili, Siyang |
Report |
Jan 1, 2017 |
2757 |
| Suppression of Retinal Neovascularization by Inhibition of Galectin-1 in a Murine Model of Oxygen-Induced Retinopathy. |
Yang, Ning; Zhang, Wenxi; He, Tao; Xing, Yiqiao |
Report |
Jan 1, 2017 |
4749 |
| Efficacy of Subconjunctival Bevacizumab Injections before and after Surgical Excision in Preventing Pterygium Recurrence. |
Nuzzi, Raffaele; Tridico, Federico |
Report |
Jan 1, 2017 |
4058 |
| Effect of Preoperative Intravitreal Bevacizumab on the Surgical Outcome of Neovascular Glaucoma at Different Stages. |
Kwon, Junki; Sung, Kyung Rim |
Report |
Jan 1, 2017 |
5683 |
| The CECARI Study: Everolimus (Certican[R]) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial. |
Van Keer, Jan; Derthoo, David; Van Caenegem, Olivier; de Pauw, Michel; Nellessen, Eric; Duerinckx, N |
|
Jan 1, 2017 |
5531 |
| Evaluation of Radiosensitizing and Anti-Angiogenesis Activity of Chelidonium majus Extract in Ehrlich Ascites Carcinoma Transplanted Mice. |
Hassan, Asmaa Abu-Bakr; Abdel-Rafei, Mohamed Khairy; Hasan, Hesham Farouk |
Report |
Dec 31, 2016 |
7093 |
| USFDA grants approval to Genentech's Avastin. |
|
|
Dec 8, 2016 |
146 |
| USFDA grants approval to Genentech's Avastin. |
|
|
Dec 8, 2016 |
142 |
| Amgen & Allergan partnership submits MAA to EMA for biosimilar candidate to Avastin (bevacizumab). |
|
|
Dec 5, 2016 |
256 |
| Tab. Everolimus 5 Mg. ( 300 Tabs ). |
|
|
Nov 17, 2016 |
396 |
| United States : Landmark study demonstrates Pfizers Celebrex (Celecoxib)has similar Cardiovascular risk as compared to prescription doses of Ibuprofen and Naproxen. |
|
|
Nov 15, 2016 |
502 |
| Tab Pazopanib 400 Mg. |
|
|
Nov 4, 2016 |
106 |
| Tablet/capsule Containing Everolimus 5mg. |
|
|
Nov 2, 2016 |
253 |
| Tablet /capsule Containing Lenalidomide 10 Mg. |
|
|
Nov 2, 2016 |
254 |
| Role of bevacizumab in the prevention of early postoperative haemorrhage after 25-gauge microincision vitrectomy surgery. |
|
Report |
Oct 31, 2016 |
2800 |
| Tablet/capsule Containing Everolimus 10mg. |
|
|
Oct 26, 2016 |
253 |
| Lenalidomide 10mg Tablet. |
|
|
Oct 25, 2016 |
179 |
| Tablet Pazopanib 400 Mg. |
|
|
Oct 25, 2016 |
252 |
| Tab Pazopanib 400 Mg. |
|
|
Oct 19, 2016 |
106 |
| United States : New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin. |
|
|
Oct 12, 2016 |
463 |
| KTH takes lead in administering Avastin injection service to eye patients. |
|
|
Oct 10, 2016 |
618 |
| Cap. Sunitinib Malate 25 Mg And 12.5 Mg In Strip Packing. ( 25 Mg. - 800 Caps, 12.5 Mg. - 600 Caps ). |
|
|
Oct 7, 2016 |
400 |
| Inj Dalteparin 7500 Iu/0.3ml.pfs. |
|
|
Sep 29, 2016 |
235 |
| Provision Of Amgros. |
|
|
Sep 27, 2016 |
363 |
| Supply of Dalteparin Sodium 10 Ml 100000 Iu Inj. |
|
|
Sep 22, 2016 |
139 |
| Completion Of A Non-inclusive Discount Agreement Pursuant To 130a Para. 8 Sgb V For Drug Dalteparin, Atc B01ab04, For The Period From 01.11.2016 Until 31.10.2018. |
|
|
Sep 20, 2016 |
197 |
| (ph No.:03113) Celecoxib 100 Mg Cap. |
|
|
Sep 16, 2016 |
116 |
| Celecoxib Capsules 200 Mg. |
|
|
Sep 12, 2016 |
124 |
| Tab Everolimus 0.25 Mg ( Brand: Certican 0.25 Mg). |
|
|
Sep 10, 2016 |
214 |
| Tab Everolimus 0.5 Mg ( Brand: Certican 0.5 Mg ). |
|
|
Sep 10, 2016 |
214 |
| Tab Pazopanib 400mg. |
|
|
Sep 8, 2016 |
120 |
| Provision Of Avastin And Drug Supply. |
|
|
Sep 1, 2016 |
137 |
| Lenalidomide 10mg Tablet. |
|
|
Aug 31, 2016 |
179 |
| Everolimus 0.75 Mg Tab, Brand- Certican. |
|
|
Aug 26, 2016 |
526 |
| Provision Of 216-3150 Drug Dalteparin 5000ui Prefilled Syringe. |
|
|
Aug 24, 2016 |
110 |
| Procurement Of Niv/card/0001 Everolimus Eluting Balloon Mounted Coronary Stent System (cobalt Chromium)-assorted Size. |
|
|
Aug 23, 2016 |
107 |
| Delivery Of The Drug Inn: Everolimus (tn: Sertikan) By Decision Of The Medical Commission To Ensure That The Patient Has The Right To Receive State Social Assistance In The Village Of Kanev Kanev District Of The Krasnodar Territory In 2016. |
|
|
Aug 19, 2016 |
116 |
| Inj Dalteparin 5000 Iu/0.2ml.pfs. |
|
|
Aug 8, 2016 |
201 |
| Tab/cap. Everolimus 0.50mg In Strip Packing. |
|
|
Aug 2, 2016 |
201 |
| Tab / Cap Everolimus 0.25mg In Strip Packing. |
|
|
Aug 2, 2016 |
201 |
| Supply Of Drugs: Everolimus. |
|
|
Aug 2, 2016 |
101 |
| Efficacy and Safety of Zhuanggu Joint Capsules in Combination with Celecoxib in Knee Osteoarthritis: A Multi-center, Randomized, Double-blind, Double-dummy, and Parallel Controlled Trial. |
Zhang, Xian-Long; Yang, Jing; Yang, Liu; Liu, Jian-Guo; Cai, Xin-Yu; Fan, Wei-Ming; Yun, Xue-Qing; M |
Report |
Aug 1, 2016 |
3796 |
| Tab Pazopanib 400mg. |
|
|
Jul 30, 2016 |
120 |
| Pvms No.-010880, Tab Tamoxifen Citrate 20mg. |
|
|
Jul 29, 2016 |
118 |
| Injection Bevacizumab 100 Mg. |
|
|
Jul 28, 2016 |
253 |
| Eisai Receives Positive CHMP Opinion on New Indication for Anticancer Agent Lenvatinib in Combination with Everolimus for Treatment of Advanced Renal Cell Carcinoma. |
|
|
Jul 22, 2016 |
1275 |
| Lenalidomide 10mg Tablet. |
|
|
Jul 22, 2016 |
179 |
| Delivery Of The Drug Group Everolimus. |
|
|
Jul 22, 2016 |
121 |
| Everolimus 0.5 mg tab. |
|
|
Jul 14, 2016 |
235 |
| Everolimus 0.75 mg tab, brand- certican. |
|
|
Jul 1, 2016 |
513 |
| Omalizumab 15Cma Inj iteir.l in Pazopanib -lOOmg Tab iteir.2 1980 Regorafenib -lOmg Tab iteir.3 560. |
|
|
Jun 18, 2016 |
128 |
| Supply Of Tigycylin 50mg Inj, Pazopanib 400mg Tab, and Mycophenolate mofetil 500mg Tab. |
|
|
Jun 13, 2016 |
113 |
| Lenalidomide 10mg tablet. |
|
|
Jun 11, 2016 |
179 |
| ?27 For Carrying Out Procurement Of Medicinal Drug Everolimus. |
|
|
Jun 11, 2016 |
277 |
| Switzerland : Roche receives EU approval of Avastin in combination with Tarceva for patients with a specific type of advanced lung cancer. |
|
|
Jun 9, 2016 |
929 |
| Everolimus 5mg tab. |
|
|
Jun 9, 2016 |
330 |
| Sunitinib Malate Market Forecast for Pancreatic Cancer, 2016-2017 - New Market Report. |
|
|
Jun 7, 2016 |
505 |
| Japan : Anti-Cancer Agent Avastin, Obtained Approval for Additional Indication of Advanced or Recurrent Cervical Cancer. |
|
|
May 24, 2016 |
290 |
| Everolimus 0.75 mg tab in strip brand- certican. |
|
|
May 20, 2016 |
515 |
| General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents. |
|
|
Apr 16, 2016 |
491 |
| Everolimus 0.75mg tab in strip, brand-certican. |
|
|
Mar 22, 2016 |
505 |
| Rate contract for injections - Bcmiparin, Bcndamustinc, Benzathine Pencillin, Benzathine penicillin, Benzyl Pcnicilline, Bevacizumab inj., Bevacizumab inj., BIB6B12,, Bleomycin, Bortezomib, Bortezomib. |
|
|
Mar 18, 2016 |
112 |
| Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis. |
Huang, Weihuan; Liang, Yeyin; Wang, Jiajian; Li, Guoqiang; Wang, Guocai; Li, Yaolan; Chung, Hau Yin |
Report |
Mar 15, 2016 |
5310 |
| Supply Of Capsule Calcitriol 0.25mcg 180, Tab Mycophenolate Mofetil 500mg 360, Tab Everolimus 0.5mg 180, Tab Everolimus 0.25mg 180, Tab Hydroxyurea 500mg. |
|
|
Mar 2, 2016 |
112 |
| Celecoxib/PLGA Suppresses Angiogenesis and Lung Metastasis of Murine Experimental Breast Cancer/ Celecoxib/PLGA Suprime Angiogenesis y Metastasis Pulmonar de un Cancer Mamario Murino Experimental. |
Roa, Ignacio; Cantin, Mario; Munoz, Mariela; Rosas, Carlos; Lemus, David |
|
Mar 1, 2016 |
4465 |
| Everolimus 0.75mg tab in strip , brand- certican. |
|
|
Feb 11, 2016 |
506 |
| Framework agreement for the supply of a medicinal product containing the active substance sorafenib tosylate for na homolce hospital. |
|
|
Jan 13, 2016 |
158 |
| Everolimus 0.75mg tab in strip. brand- certican 0.75mg. |
|
|
Jan 12, 2016 |
515 |
| Propofol Suppressed Hypoxia/Reoxygenation-Induced Apoptosis in HBVSMC by Regulation of the Expression of Bcl-2, Bax, Caspase3, Kir6.1, and p-JNK. |
Zhang, Jianhai; Xia, Yunfei; Xu, Zifeng; Deng, Xiaoming |
|
Jan 1, 2016 |
5450 |
| Soy Isoflavone Protects Myocardial Ischemia/Reperfusion Injury through Increasing Endothelial Nitric Oxide Synthase and Decreasing Oxidative Stress in Ovariectomized Rats. |
|
|
Jan 1, 2016 |
7224 |
| Dalteparin sodium 5000 units pfs injection. |
|
|
Dec 31, 2015 |
106 |
| Dalteparin sodium 5000 units pfs injection. |
|
|
Dec 20, 2015 |
106 |
